G1 Therapeutics' IPO

G1 Therapeutics raised a round of funding on May 17, 2017. Investors include Public.

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. The company is advancing a pipeline of potenti…

Articles about G1 Therapeutics' IPO: